“REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY: Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021012, Dec. 2020, doi: 10.4084/mjhid.2021.012.